Management of patients with diabetic macular edema switched from dexamethasone intravitreal implant to fluocinolone acetonide intravitreal implant

HIGHLIGHTS

  • who: Stu00e9phanie Baillif and colleagues from the Department of Ophthalmology, Hu00f4pital Pasteur, Centre Hospitalier Universitaire de Nice, Universitu00e9, Voie Romaine, Nice, France Department of Ophthalmology, Bordeaux University Hospital, Bordeaux, France have published the research work: Management of Patients with Diabetic Macular Edema Switched from Dexamethasone Intravitreal Implant to Fluocinolone Acetonide Intravitreal Implant, in the Journal: Pharmaceutics 2022, 14, x FOR PEER REVIEW the evolution of /2022/
  • what: The authors observed an increase in VA during the follow-up, showing that FAc could offer additional benefits in patients treated with DEX implants.
  • how: The . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?